Sodium transporters and aquaporins: Future renal biomarkers?;Transportadores de sodio y aquaporinas: ¿futuros biomarcadores renales?

Medicina Clinica

Volumn 129, Issue 11, 2007, Pages 433-437

  Esteva Font, Cristina ^a,b   Balcells, Roser Torra ^a   Fernández Llama, Patricia ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b FUNDACIÓ PUIGVERT   (Spain)

Author keywords

Aquaporin 2; Renal reabsorption; Urinary biomarkers

Indexed keywords

AQUAPORIN; AQUAPORIN 1; AQUAPORIN 2; BIOLOGICAL MARKER; SODIUM CHLORIDE COTRANSPORTER; SODIUM PHOSPHATE COTRANSPORTER 2; SODIUM POTASSIUM CHLORIDE COTRANSPORTER; SODIUM PROTON EXCHANGE PROTEIN 3;

DISEASE COURSE; EPITHELIUM; EXPERIMENTAL STUDY; FLUID BALANCE; GLOMERULUS FILTRATION; HUMAN; KIDNEY COLLECTING TUBULE; KIDNEY DISEASE; KIDNEY DISTAL TUBULE; KIDNEY PROXIMAL TUBULE; NEPHRON; PATHOPHYSIOLOGY; PROTEIN FUNCTION; REVIEW; SODIUM ABSORPTION; SODIUM TRANSPORT;

EID: 35348833015     PISSN: 00257753     EISSN: 15788989     Source Type: Journal    
DOI: 10.1157/13110477     Document Type: Review

References (44)

1. Fernández-Llama P, Andrews P, Ecelbarger CA, Nielsen S, Knepper M. Concentrating defect in experimental nephrotic syndrone: altered expression of aquaporins and thick ascending limb Na+ transporters. Kidney Int. 1998;54:170-9.
2. McKee JA, Kumar S, Ecelbarger CA, Fernández-Llama P, Terris J, Knepper MA. Detection of Na(+) transporter proteins in urine. J Am Soc Nephrol. 2000;11:2128-32.
3. Pisitkun T, Shen RF, Knepper MA. Identification and proteomic profiling of exosomes in human urine. Proc Natl Acad Sci U S A. 2004;101:13368-73.
4. Kwon TH, Nielsen J, Kim YH, Knepper MA, Frokiaer J, Nielsen S. Regulation of sodium transporters in the thick ascending limb of rat kidney: response to angiotensin II. Am J Physiol Renal Physiol. 2003;285:F152-65.
5. Wiederkehr MR, Di SF, Collazo R, Quinones H, Fan L, Murer H, et al. Characterization of acute inhibition of Na/H exchanger NHE-3 by dopamine in opossum kidney cells. Kidney Int. 2001;59:197-209.
6. Greger R. Physiology of renal sodium transport. Am J Med Sci. 2000;319:51-62.
7. Burckhardt G, Di SF, Helmle-Kolb C. The Na+/H+ exchanger gene family. J Nephrol. 2002;15 Suppl 5:S3-21.
8. Nakamura S, Amlal H, Schultheis PJ, Galla JH, Shull GE, Soleimani M. HCO-3 reabsorption in renal collecting duct of NHE-3-deficient mouse: a compensatory response. Am J Physiol. 1999;276:F914-21.
9. Bacic D, Lehir M, Biber J, Kaissling B, Murer H, Wagner CA. The renal Na+/phosphate cotransporter NaPi-IIa is internalized via the receptormediated endocytic route in response to parathyroid hormone. Kidney Int. 2006;69:495-503.
10. Bergwitz C, Roslin NM, Tieder M, Loredo-Osti JC, Bastepe M, bu-Zahra H, et al. SLC34A3 mutations in patients with hereditary hypophosphatemic rickets with hypercalciuria predict a key role for the sodium-phosphate cotransporter NaPi-IIc in maintaining phosphate homeostasis. Am J Hum Genet. 2006;78:179-92.
11. King LS, Choi M, Fernandez PC, Cartron JP, Agre P. Defective urinary-concentrating ability due to a complete deficiency of aquaporin-1. N Engl J Med. 2001;345:175-9.
12. Greger R. Physiology of renal sodium transport. Am J Med Sci. 2000;319:51-62.
13. Kim GH, Ecelbarger CA, Mitchell C, Packer RK, Wade JB, Knepper MA. Vasopressin increases Na-K-2Cl cotransporter expression in thick ascending limb of Henle's loop. Am J Physiol. 1999;276:F96-103.
14. Greger R. Physiology of renal sodium transport. Am J Med Sci. 2000;319:51-62.
15. Fernandez-Llama P, Ecelbarger CA, Ware JA, Andrews P, Lee AJ, Turner R, et al. Cyclooxygenase inhibitors increase Na-K-2Cl cotransporter abundance in thick ascending limb of Henle's loop. Am J Physiol. 1999;277:F219-26.
16. Starremans PG, Kersten FF, Knoers NV, Van den Heuvel LP, Bindels RJ. Mutations in the human Na-K-2Cl cotransporter (NKCC2) identified in Bartter syndrome type I consistently result in nonfunctional transporters. J Am Soc Nephrol. 2003;14:1419-26.
17. Lang F, Capasso G, Schwab M, Waldegger S. Renal tubular transport and the genetic basis of hypertensive disease. Clin Exp Nephrol. 2005;9:91-9.
18. Hoagland KM, Flasch AK, Dahly-Vernon AJ, Dos Santos EA, Knepper MA, Roman RJ. Elevated BSC-1 and ROMK expression in Dahl salt-sensitive rat kidneys. Hypertension. 2004;43:860-5.
19. Kim GH, Masilamani S, Turner R, Mitchell C, Wade JB, Knepper MA. The thiazide-sensitive Na-Cl cotransporter is an aldosterone-induced protein. Proc Natl Acad Sci U S A. 1998;95:14552-7.
20. Verlander JW, Tran TM, Zhang L, Kaplan MR, Hebert SC. Estradiol enhances thiazide-sensitive NaCl cotransporter density in the apical plasma membrane of the distal convoluted tubule in ovariectomized rats. J Clin Invest. 1998;101:1661-9.
21. Ecelbarger CA, Kim GH, Wade JB, Knepper MA. Regulation of the abundance of renal sodium transporters and channels by vasopressin. Exp Neurol. 2001;171:227-34.
22. Reissinger A, Ludwig M, Utsch B, Promse A, Baulmann J, Weisser B, et al. Novel NCCT gene mutations as a cause of Gitelman's syndrome and a systematic review of mutant and polymorphic NCCT alleles. Kidney Blood Press Res. 2002;25:354-62.
23. Gamba G. Role of WNK kinases in regulating tubular salt and potassium transport and in the development of hypertension. Am J Physiol Renal Physiol. 2005;288:F245-52.
24. Masilamani S, Kim GH, Mitchell C, Wade JB, Knepper MA. Aldosterone-mediated regulation of ENaC alpha, beta, and gamma subunit proteins in rat kidney. J Clin Invest. 1999;104:R19-23.
25. Snyder PM, Price MP, McDonald FJ, Adams CM, Volk KA, Zeiher BG, et al. Mechanism by which Liddle's syndrome mutations increase activity of a human epithelial Na+ channel. Cell. 1995;83:969-78.
26. Arai K, Zachman K, Shibasaki T, Chrousos GP. Polymorphisms of amiloride-sensitive sodium channel subunits in five sporadic cases of pseudohypoaldosteronism: do they have pathologic potential? J Clin Endocrinol Metab. 1999;84:2434-7.
27. Chang SS, Grunder S, Hanukoglu A, Rosler A, Mathew PM, Hanukoglu I, et al. Mutations in subunits of the epithelial sodium channel cause salt wasting with hyperkalaemic acidosis, pseudohypoaldosteronism type 1. Nat Genet. 1996;12:248-53.
28. Deen PM, Verdijk MA, Knoers NV, Wieringa B, Monnens LA, Van Os CH, et al. Requirement of human renal water channel aquaporin-2 for vasopressin-dependent concentration of urine. Science. 1994;264:92-5.
29. Fernández-Llama P. Fisiología molecular del mecanismo de concentración urinario, papel de las aquaporinas renales. Nefrologia. 2000;20:486-94.
30. Nielsen S, Frokiaer J, Marples D, Kwon TH, Agre P, Knepper MA. Aquaporins in the kidney: from molecules to medicine. Physiol Rev. 2002;82:205-44.
31. Zelenina M, Christensen BM, Palmer J, Nairn AC, Nielsen S, Aperia A. Prostaglandin E(2) interaction with AVP: effects on AQP2 phosphorylation and distribution. Am J Physiol Renal Physiol. 2000;278:F388-94.
32. Valenti G, Procino G, Tamma G, Carmosino M, Svelto M. Minireview: aquaporin 2 trafficking. Endocrinology. 2005;146:5063-70.
33. Morello JP, Bichet DG. Nephrogenic diabetes insipidus. Annu Rev Physiol. 2001;63:607-30.
34. Du Cheyron CD, Daubin C, Poggioli J, Ramakers M, Houillier P, Charbonneau P, et al. Urinary measurement of Na+/H+ exchanger isoform 3 (NHE3) protein as new marker of tubule injury in critically ill patients with ARF. Am J Kidney Dis. 2003;42:497-506.
35. Kanno K, Sasaki S, Hirata Y, Ishikawa S, Fushimi K, Nakanishi S, et al. Urinary excretion of aquaporin-2 in patients with diabetes insipidus. N Engl J Med. 1995;332:1540-5.
36. Sisson D, Batlle D. Aquaporin-2 as a biomarker of distal renal tubular function using lithium as an experimental model. Ren Fail. 1999;21:331-6.
37. Deen PM, Van Aubel RA, Van Lieburg AF, Van Os CH. Urinary content of aquaporin 1 and 2 in nephrogenic diabetes insipidus. J Am Soc Nephrol. 1996;7:836-41.
38. Norgaard JP, Djurhuus JC, Watanabe H, Stenberg A, Lettgen B. Experience and current status of research into the pathophysiology of nocturnal enuresis. Br J Urol. 1997;79:825-35.
39. Radetti G, Paganini C, Rigon F, Gentili L, Gebert U, Ishikawa S. Urinary aquaporin-2 excretion in nocturnal enuresis. Eur J Endocrinol. 2001;145:435-8.
40. Pedersen RS, Bentzen H, Bech JN, Nyvad O, Pedersen EB. Urinary aquaporin-2 in healthy humans and patients with liver cirrhosis and chronic heart failure during baseline conditions and after acute water load. Kidney Int. 2003;63:1417-25.
41. Ivarsen P, Frokiaer J, Aagaard NK, Hansen EF, Bendtsen F, Nielsen S, et al. Increased urinary excretion of aquaporin 2 in patients with liver cirrhosis. Gut. 2003;52:1194-9.
42. Esteva-Font C, Baccaro ME, Fernandez-Llama P, Sans L, Guevara M, Ars E, et al. Aquaporin-1 and aquaporin-2 urinary excretion in cirrhosis: Relationship with ascites and hepatorenal syndrome. Hepatology. 2006;44:1555-63.
43. Schrier RW, Cadnapaphornchai MA, Umenishi F. Water-losing and water-retaining states: role of water channels and vasopressin receptor antagonists. Heart Dis. 2001;3:210-4.
44. Funayama H, Nakamura T, Saito T, Yoshimura A, Saito M, Kawakami M, et al. Urinary excretion of aquaporin-2 water channel exaggerated dependent upon vasopressin in congestive heart failure. Kidney Int. 2004;66:1387-92.